Total Credits: .5 including .5 AOA Category 1-A Credit(s)
At the conclusion of this session, the participant should be able to:
ACCREDITATION
The Pennsylvania Osteopathic Medical Association (POMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. POMA designates this activity for a maximum of 1 Category 1-A AOA CME credits and will report CME and specialty credits to the AOA commensurate with the extent of the physician’s participation in this activity.
GRIEVANCE POLICY STATEMENT
It is the policy of the POMA that any physician dissatisfied with the CME program will be issued a refund upon request, and no CME credits will be reported to the AOA. Complaints on Evaluation Forms are also taken into consideration when planning future CME programs and may lead to changes in the format or content." If you have any questions or concerns about this educational experience, you may call the POMA office at (717) 939-9318 or send an email message to cme@poma.org. All questions or concerns will be addressed promptly.
| Condoluci, Mark - Handout - Emerging Pathogens (1.65 MB) | Available after Purchase | ||
Mark J. Condoluci, DO, MHA, FACOI, “Emerging Pathogens in 2025,” and “Anal Cancer Screening,” is a physician at Jefferson Health New Jersey Infectious Diseases in New Jersey. Board certified in internal medicine and infectious disease, Dr. Condoluci is a graduate of Loyola College in Baltimore, Maryland, and a 2010 graduate of PCOM. He completed an internal medicine residency at the University of Medicine and Dentistry of New Jersey School of Medicine and an infectious disease fellowship at Garden State Infectious Diseases Associates at Rowan University in Voorhees, NJ. He is a member of Infectious Diseases Society of America, the American Osteopathic Association, and the New Jersey Association of Osteopathic Physicians.
Dr. Condoluci has no relevant financial relationship(s) with ineligible companies to disclose.
|
Primary Care Approach to Diagnosis and Evaluation of Pulmonary Hypertension
Original Program Date: 05/09/2025 |
